Identification of a novel missense variant in SPDL1 associated with idiopathic pulmonary fibrosis
Dhindsa, R. S.; Mattsson, J.; Nag, A.; Wang, Q.; Wain, L. V.; Allen, R.; Wigmore, E. M.; Ibanez, K.; Vitsios, D.; Deevi, S. V. V.; Wasilewski, S.; Karlsson, M.; Lassi, G.; Olsson, H.; Muthas, D.; Mackay, A.; Murray, L.; Young, S.; Haefliger, C.; FinnGen Consortium, ; Maher, T. M.; Belvisi, M. G.; Jenkins, G.; Molyneaux, P.; Platt, A.; Petrovski, S.
Show abstract
Idiopathic pulmonary fibrosis (IPF) is a fatal disorder characterised by progressive, destructive lung scarring. Despite significant progress, the genetic determinants of this disease remain incompletely defined. Using next generation sequencing data from 752 individuals with sporadic IPF and 119,055 controls, we performed both variant- and gene-level analyses to identify novel IPF genetic risk factors. Our variant-level analysis revealed a novel rare missense variant in SPDL1 (NM_017785.5 p.Arg20Gln; p = 2.4 x 10-7, odds ratio = 2.87). This signal was independently replicated in the FinnGen cohort (combined p = 2.2 x 10-20), firmly associating this variant as a novel IPF risk allele. SPDL1 encodes Spindly, a protein involved in mitotic checkpoint signalling during cell division that has not been previously described in fibrosis. Our results highlight a novel mechanism underlying IPF, providing the potential for new therapeutic discoveries in a disease of great unmet need.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Genome-wide analysis in 756,646 individuals provides first genetic evidence that ACE2 expression influences COVID-19 risk and yields genetic risk scores predictive of severe disease 96%
- Systematic assessment of regulatory effects of human disease variants in pluripotent cells 96%
- Central role of glycosylation processes in human genetic susceptibility to SARS-CoV-2 infections with Omicron variants 95%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Genetic association analysis of 269 rare diseases reveals novel aetiologies 96%
- Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19 95%
- Human loss-of-function variants suggest that partial LRRK2 inhibition is a safe therapeutic strategy for Parkinsons disease 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.